Older U.S. adults who received the recombinant shingles vaccine had a lower incidence rate of dementia than their peers.

The US FDA blocked the release of several studies that backed the safety of vaccines for COVID-19 and shingles. The studies were conducted by the agency's scientists and found serious side effects ...

Research found that vaccinated individuals were 46 per cent less likely to suffer major cardiac events. Doctors explain what ...

Giving a respiratory syncytial virus (RSV) vaccine at the same time as a shingles vaccine produces a similar immune response ...

Vaccination against herpes zoster, or shingles, was tied to fewer deaths among people with dementia, an analysis of data in Wales showed. Zoster vaccination also was tied to a drop of 3.1 percentage ...

Share on Pinterest Elizabeth Gomez, 54, of Huntington Park, right, receives a Prevnar and shingles vaccine by pharmacy manager Sandra Gonzalez at CVS in Huntington Park on August 28, 2024. Image ...

Researchers estimate that during their lifetime, one out of every three people will develop shingles — a viral condition causing an extremely painful rash that eventually blisters. Since 2006, older ...

The shingles vaccine can significantly reduce the chance of developing vascular dementia, while also lowering the risk of blood clots, heart attacks and death in people ages 50 and older, according to ...

While lifesaving vaccines face a relentless onslaught from the Trump administration—with fervent anti-vaccine advocate Robert F. Kennedy Jr. leading the charge—scientific literature is building a ...

A clever natural experiment in Canada suggests a routine shingles vaccine may do more than prevent rash. Instead, the vaccine could help delay the onset of dementia in later life. Study: Herpes zoster ...